{"id":"https://openalex.org/W1636375730","doi":null,"title":"Effect of some Artemisinin and Combination Therapy Regimens with and without Concomitant Administration of Phospholipids on the Levels of Plasma Aminotransferases and Bilirubin in Nigerian Male Subjects","display_name":"Effect of some Artemisinin and Combination Therapy Regimens with and without Concomitant Administration of Phospholipids on the Levels of Plasma Aminotransferases and Bilirubin in Nigerian Male Subjects","publication_year":2013,"publication_date":"2013-03-31","ids":{"openalex":"https://openalex.org/W1636375730","mag":"1636375730"},"language":"en","primary_location":{"id":"mag:1636375730","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Olorunfemi_Eseyin/publication/266387209_Effect_of_some_Artemisinin_and_Combination_Therapy_Regimens_with_and_without_Concomitant_Administration_of_Phospholipids_on_the_Levels_of_Plasma_Aminotransferases_and_Bilirubin_in_Nigerian_Male_Subjects/links/542f28e60cf277d58e91eeb5.pdf?disableCoverPage=true","pdf_url":null,"source":{"id":"https://openalex.org/S2764395326","display_name":"The African Journal of Pharmacology and Therapeutics","issn_l":"2303-9841","issn":["2303-9841"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The African Journal of Pharmacology and Therapeutics","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102316245","display_name":"Emmanuel I. Etim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emmanuel I. Etim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111474633","display_name":"Etienne E. Essien","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Etienne E. Essien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050486150","display_name":"Olorunfemi Abraham Eseyin","orcid":"https://orcid.org/0000-0002-8232-7634","observed_orcids":["https://orcid.org/0000-0002-8232-7634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olorunfemi A. Eseyin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8232-7634","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5001611005","display_name":"Imo E. Udoh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Imo E. Udoh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.06283901,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"2","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.4957999885082245,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.4171999990940094,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/artemisinin","display_name":"artemisinin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/antimalarial-combination-therapy","display_name":"combination antimalarial therapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/phospholipids","display_name":"phospholipids","score":0.8330000042915344},{"id":"https://openalex.org/keywords/aminotransferases","display_name":"transaminases","score":0.8970000147819519},{"id":"https://openalex.org/keywords/liver-enzymes","display_name":"liver enzymes","score":0.6570000052452087},{"id":"https://openalex.org/keywords/bilirubin","display_name":"bilirubin","score":0.9179999828338623},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.843999981880188},{"id":"https://openalex.org/keywords/amodiaquine","display_name":"amodiaquine","score":0.9020000100135803},{"id":"https://openalex.org/keywords/mefloquine","display_name":"mefloquine","score":1.0},{"id":"https://openalex.org/keywords/sulfadoxine-pyrimethamine","display_name":"sulfadoxine-pyrimethamine","score":0.925000011920929},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C2776120307","wikidata":"https://www.wikidata.org/wiki/Q426921","display_name":"Artemisinin","level":4,"score":0.8197963237762451},{"id":"https://openalex.org/C2776992834","wikidata":"https://www.wikidata.org/wiki/Q239569","display_name":"Amodiaquine","level":4,"score":0.7720330357551575},{"id":"https://openalex.org/C2777199930","wikidata":"https://www.wikidata.org/wiki/Q736270","display_name":"Mefloquine","level":4,"score":0.7489840984344482},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.7195785641670227},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5602794289588928},{"id":"https://openalex.org/C2777513400","wikidata":"https://www.wikidata.org/wiki/Q104219","display_name":"Bilirubin","level":2,"score":0.5593922734260559},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5285778641700745},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.519656777381897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3524067997932434},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.19978827238082886},{"id":"https://openalex.org/C2777425658","wikidata":"https://www.wikidata.org/wiki/Q422438","display_name":"Chloroquine","level":3,"score":0.09792327880859375},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09365776181221008},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1636375730","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Olorunfemi_Eseyin/publication/266387209_Effect_of_some_Artemisinin_and_Combination_Therapy_Regimens_with_and_without_Concomitant_Administration_of_Phospholipids_on_the_Levels_of_Plasma_Aminotransferases_and_Bilirubin_in_Nigerian_Male_Subjects/links/542f28e60cf277d58e91eeb5.pdf?disableCoverPage=true","pdf_url":null,"source":{"id":"https://openalex.org/S2764395326","display_name":"The African Journal of Pharmacology and Therapeutics","issn_l":"2303-9841","issn":["2303-9841"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The African Journal of Pharmacology and Therapeutics","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W70826737","https://openalex.org/W1541724416","https://openalex.org/W1541759393","https://openalex.org/W1551586253","https://openalex.org/W1965763445","https://openalex.org/W1966124517","https://openalex.org/W1969729759","https://openalex.org/W2006270193","https://openalex.org/W2022568413","https://openalex.org/W2028628201","https://openalex.org/W2091560114","https://openalex.org/W2098923921","https://openalex.org/W2106780703","https://openalex.org/W2116874804","https://openalex.org/W2140124435","https://openalex.org/W2141596134","https://openalex.org/W2145050940","https://openalex.org/W2145130342","https://openalex.org/W2157068874","https://openalex.org/W2158292556","https://openalex.org/W2163117814","https://openalex.org/W2181657564","https://openalex.org/W2415857352"],"related_works":["https://openalex.org/W2605944336","https://openalex.org/W7164995182","https://openalex.org/W1552167726","https://openalex.org/W1977225260","https://openalex.org/W2029734218","https://openalex.org/W2110456860","https://openalex.org/W7219954101","https://openalex.org/W7100811256","https://openalex.org/W2991568879","https://openalex.org/W2607267571"],"abstract_inverted_index":{"Results:":[0],"Co-administration":[1],"of":[2,17,25,67,78,84,94],"ART":[3,35,47,61,68,107,124],"with":[4,72,132],"amodiaquine":[5],"(AMQ),":[6],"mefloquine":[7],"(MFQ)":[8],"and":[9,30,42,56,65,69,74,88,92,118],"sulphadoxine/pyremethamine":[10],"(SP)":[11],"respectively,":[12],"on":[13,99,115],"the":[14,18,21,70,82,85,95,116,130,135],"4th":[15,100],"day":[16],"studies":[19],"increased":[20,38,52,96],"mean":[22],"plasma":[23],"concentration":[24],"AST":[26],"to":[27,39,53],"80.70%,":[28],"108.0%":[29],"75.0%":[31],"against":[32,44,58],"59%":[33],"for":[34,46,60],"alone;":[36,48],"ALT":[37,87],"104%,":[40],"33.0%":[41],"43.30%":[43],"25.05%":[45],"total":[49],"bilirubin":[50],"(TBIL)":[51],"80.0%,":[54],"78.88%":[55],"98.91%":[57],"17.6%":[59],"alone.":[62],"The":[63,103],"co-administration":[64,131],"post-administration":[66],"ACTs":[71],"900mg":[73],"1800mg":[75],"daily":[76],"dose":[77],"PL":[79],"respectively":[80,98],"reduced":[81],"levels":[83],"AST,":[86],"BIL":[89],"by":[90],"65.0%":[91],"97.0%":[93],"values":[97],"day.":[101],"Discussion:":[102],"results":[104],"suggest":[105],"that":[106],"as":[108],"a":[109],"monotherapeutic":[110],"agent":[111],"has":[112],"injurious":[113],"effect":[114,120],"liver,":[117],"this":[119],"is":[121,125],"aggravated":[122],"when":[123],"used":[126],"in":[127],"ACTs,":[128],"however,":[129],"phospholipids":[133],"cushions":[134],"adverse":[136],"effects.":[137]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}